Comparative study of lansoprazole and esomeprazole in first-line triple therapy for Helicobacter pylori infection-an open label randomized controlled trial

被引：0
|
作者：
Noda, Teruyo [1 ]
Tamaki, Hiroyuki [1 ]
Arasawa, Shuichi [1 ]
Izuta, Masako [1 ]
Kubo, Atsushi [1 ]
Ogawa, Chikara [1 ]
Matsunaka, Toshihiro [1 ]
Shibatouge, Mitsushige [1 ]
机构：
[1] Takamatsu Red Cross Hosp, Takamatsu, Kagawa, Japan
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2015年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1418
引用
收藏
页码：123 / 123
页数：1
相关论文
共 50 条
  • [21] Randomized Clinical Trial: Esomeprazole, Bismuth, Levofloxacin, and Amoxicillin or Cefuroxime as First-Line Eradication Regimens for Helicobacter pylori Infection
    Wei Fu
    Zhiqiang Song
    Liya Zhou
    Yan Xue
    Yu Ding
    Baojun Suo
    Xueli Tian
    Li Wang
    [J]. Digestive Diseases and Sciences, 2017, 62 : 1580 - 1589
  • [22] New regimens as first-line eradication therapy for Helicobacter pylori infection in patients allergic to penicillin: A randomized controlled trial
    Zhang, Yuxin
    Suo, Baojun
    Tian, Xueli
    Zhang, Hua
    Lu, Haoping
    Yao, Xingyu
    Li, Cailing
    Ren, Xinlu
    Zhou, Liya
    Song, Zhiqiang
    [J]. HELICOBACTER, 2023, 28 (02)
  • [23] Effects of N-acetylcysteine on First-Line Sequential Therapy for Helicobacter pylori Infection: A Randomized Controlled Pilot Trial
    Yoon, Hyuk
    Lee, Dong Ho
    Jang, Eun Sun
    Kim, Jaihwan
    Shin, Cheol Min
    Park, Young Soo
    Hwang, Jin-Hyeok
    Kim, Jin-Wook
    Jeong, Sook-Hayng
    Kim, Nayoung
    [J]. GUT AND LIVER, 2016, 10 (04) : 520 - 525
  • [24] Quadruple therapy with vonoprazan 20 mg daily as a first-line treatment for Helicobacter pylori infection: A single-center, open-label, noninferiority, randomized controlled trial
    Lu, Lifen
    Wang, Yujing
    Ye, Jun
    Han, Yuehua
    Lou, Guochun
    Li, Yan
    Yan, Huihui
    Du, Qin
    [J]. HELICOBACTER, 2023, 28 (01)
  • [25] A Comparative Study of Sequential Therapy and Standard Triple Therapy for Helicobacter pylori Infection: A Randomized Multicenter Trial
    Zhou, Liya
    Zhang, Jianzhong
    Chen, Minhu
    Hou, Xiaohua
    Li, Zhaoshen
    Song, Zhiqiang
    He, Lihua
    Lin, Sanren
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2014, 109 (04): : 535 - 541
  • [26] A Comparative Study of Sequential Therapy and Standard Triple Therapy for Helicobacter pylori Infection: A Randomized Multicenter Trial
    Zhou, Liya
    Zhang, Jianzhong
    Chen, Minhu
    Hou, Xiaohua
    Li, Zhaoshen
    Song, Zhiqiang
    He, Lihua
    Lin, Sanren
    [J]. GASTROENTEROLOGY, 2014, 146 (05) : S396 - S396
  • [27] Optimal duration of concomitant nonbismuth quadruple therapy as first-line therapy for Helicobacter pylori: a prospective, open-label, comparative study
    Kapizioni, Christina
    Koutoufaris, Georgios
    Ntouli, Vasiliki
    Makris, Konstantinos
    Milioni, Konstantia
    Kourkoulis, Panagiotis
    Giannelis, Panagiotis
    Mellos, Aristotelis
    Michalopoulos, Georgios
    Vrakas, Spyridon
    Xourgias, Vasileios
    [J]. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2019, 31 (10) : 1206 - 1210
  • [28] First-line triple therapy with levofloxacin for Helicobacter pylori eradication
    Gisbert, J. P.
    Fernandez Bermejo, M.
    Molina Infante, J.
    Perez Gallardo, B.
    Prieto Bermejo, A.
    Mateos Rodriguez, J.
    Robledo Andres, P.
    Gonzalez Garcia, G.
    [J]. HELICOBACTER, 2007, 12 (04) : 432 - 432
  • [29] Esomeprazole Versus Lansoprazole in Triple Therapy for Eradication of Helicobacter pylori in Japan: A Multicenter, Randomized Study by the Osaka Gut Forum
    Nishida, Tsutomu
    Tsujii, Masahiko
    Tanimura, Hirohisa
    Tsutsui, Shusaku
    Tsuji, Shingo
    Takeda, Akira
    Inoue, Atsuo
    Fukui, Hiroyuki
    Yoshio, Toshiyuki
    Kishida, Osamu
    Ogawa, Hiroyuki
    Oshita, Masahide
    Kobayashi, Ichizo
    Zushi, Shinichiro
    Ichiba, Makoto
    Uenoyama, Naoto
    Yasunaga, Yuichi
    Ishihara, Ryu
    Yura, Mamoru
    Komori, Masato
    Egawa, Satoshi
    Iijima, Hideki
    Takehara, Tetsuo
    [J]. GASTROENTEROLOGY, 2014, 146 (05) : S742 - S742
  • [30] First-line triple therapy with levofloxacin for Helicobacter pylori eradication
    Gisbert, J. P.
    Fernandez-Bermejo, M.
    Molina-Infante, J.
    Perez-Gallardo, B.
    Prieto-Bermejo, A.-B.
    Mateos-Rodriguez, J.-M.
    Robledo-Andres, P.
    Gonzalez-Garcia, G.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2007, 26 (03) : 495 - 500
12345